scholarly journals MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

2015 ◽  
Vol 11 (8) ◽  
pp. 471-482 ◽  
Author(s):  
Àlex Rovira ◽  
◽  
Mike P. Wattjes ◽  
Mar Tintoré ◽  
Carmen Tur ◽  
...  
2020 ◽  
Vol 6 (3) ◽  
pp. 205521732094678 ◽  
Author(s):  
Nik Sol ◽  
Cyra E Leurs ◽  
Sjors GJG In ’t Veld ◽  
Eva M Strijbis ◽  
Adrienne Vancura ◽  
...  

Background In multiple sclerosis (MS), clinical assessment, MRI and cerebrospinal fluid are important in the diagnostic process. However, no blood biomarker has been confirmed as a useful tool in the diagnostic work-up. Objectives Blood platelets contain a rich spliced mRNA repertoire that can alter during megakaryocyte development but also during platelet formation and platelet circulation. In this proof of concept study, we evaluate the diagnostic potential of spliced blood platelet RNA for the detection of MS. Methods We isolated and sequenced platelet RNA of blood samples obtained from 57 MS patients and 66 age- and gender-matched healthy controls (HCs). 60% was used to develop a particle swarm-optimized (PSO) support vector machine classification algorithm. The remaining 40% served as an independent validation series. Results In total, 1249 RNAs with differential spliced junction expression levels were identified between platelets of MS patients as compared to HCs, including EPSTI1, IFI6, and RPS6KA3, in line with reported inflammatory signatures in the blood of MS patients. The RNAs were subsequently used as input for a MS classifier, capable of detecting MS with 80% accuracy in the independent validation series. Conclusions Spliced platelet RNA may enable the blood-based diagnosis of MS, warranting large-scale validation.


2013 ◽  
Vol 115 (10) ◽  
pp. 2033-2040 ◽  
Author(s):  
Dirk De Ridder ◽  
Frank Van Der Aa ◽  
Jan Debruyne ◽  
Marie-Beatrice D’hooghe ◽  
Benedicte Dubois ◽  
...  

2016 ◽  
Vol 15 (3) ◽  
pp. 292-303 ◽  
Author(s):  
Massimo Filippi ◽  
Maria A Rocca ◽  
Olga Ciccarelli ◽  
Nicola De Stefano ◽  
Nikos Evangelou ◽  
...  

2015 ◽  
Vol 156 (37) ◽  
pp. 1514-1518
Author(s):  
Vitalie Văcăraș ◽  
Zoltán Zsigmond Major ◽  
Emilia Mariș ◽  
Kinga Andrea Major ◽  
Anca Dana Buzoianu

Stroke-like presentation of multiple sclerosis is a challenging diagnosis requiring quick and efficient decision in order to provide the best possible therapeutical option. This case presentation focuses on the difficulties of the differential diagnostic process. Even if signs were misleading, the stepwise and structured approach with the use of adequate diagnostic tools revealed the most likely diagnosis and, thus, assured the best clinical care. Orv. Hetil., 2015, 156(37), 1514–1518.


2019 ◽  
Vol 26 (4) ◽  
pp. 489-500 ◽  
Author(s):  
Laura Barin ◽  
Christian P Kamm ◽  
Anke Salmen ◽  
Holger Dressel ◽  
Pasquale Calabrese ◽  
...  

Background: Diagnosing multiple sclerosis (MS) early is crucial to avoid future disability. However, potentially preventable delays in the diagnostic cascade from contact with a physician to definite diagnosis still occur and their causes are still unclear. Objective: To identify the possible causes of delays in the diagnostic process. Methods: We analyzed the data of the Swiss MS Registry. With logistic regression, we modeled the time from the first contact to the first consultation (contact-to-evaluation time, ⩽1 month/>1 month) and the evaluation-to-diagnosis time (⩽6 months/>6 months). Potential factors were health system characteristics, sociodemographic variables, first symptoms, and MS type. Results: We included 522 participants. Mostly, general practitioners (67%) were contacted first, without delaying the diagnosis. In contrast, first symptoms and MS type were the major contributors to delays: gait problems were associated with longer contact-to-evaluation times, depression as a concomitant symptom with longer evaluation-to-diagnosis times, and having primary progressive MS prolonged both phases. In addition, living in mountainous areas was associated with longer contact-to-evaluation times, whereas diagnosis after 2000 was associated with faster diagnoses. Conclusion: For a quicker diagnosis, awareness of MS as a differential diagnosis of gait disorders and the co-occurrence of depression at onset should be raised, and these symptoms should be attentively followed.


Author(s):  
Dejan Jakimovski ◽  
Michael G Dwyer ◽  
Niels Bergsland ◽  
Bianca Weinstock-Guttman ◽  
Robert Zivadinov

The continuous neuroinflammatory and neurodegenerative pathology in multiple sclerosis (MS) results in irreversible accumulation of physical and cognitive disability. Reliable early detection of MS disease processes can aid in the diagnosis, monitoring and treatment management of MS patients. Recent assay technological advancements now allow reliable quantification of serum-based neurofilament light chain (sNfL) levels, which provide temporal information regarding the degree of neuroaxonal damage. The relationship and predictive value of sNfL with clinical and cognitive outcomes, other paraclinical measures and treatment response is reviewed. sNfL measurement is an emerging, noninvasive and disease-responsive MS biomarker that is currently utilized in research and clinical trial settings. Understanding sNfL confounders and further assay standardization will allow clinical implementation of this biomarker.


1993 ◽  
Vol 10 (2) ◽  
pp. 86-92 ◽  
Author(s):  
Ashley Craig

Difficulties can arise in correctly diagnosing clients who present with mood and anxiety disturbances. Unless a detailed history is taken and a comprehensive interview performed, errors of diagnosis are likely to occur which may result in aversive consequences. To illustrate this likelihood, two cases of persons exhibiting anxiety and mood disturbance are briefly reported. The first case involved a prior diagnosis of psychogenic disorder (Mood Disorder). However, further investigation of the client's symptoms revealed that the anxiety and depression were secondary and caused by an underlying organic disorder. The second case involved a prior diagnosis of a physically based disorder presenting with anxiety and depression (Multiple Sclerosis). However, further investigation of the client's symptoms revealed that the somatic symptoms were secondary and the mood and anxiety disturbance were primary symptoms. A model is presented as a guide to better understand the diagnostic process, comments upon the need for a detailed history and interview are offered, and problems arising from incorrect diagnoses are discussed.


2020 ◽  
Vol 11 ◽  
Author(s):  
Fiona Roberts ◽  
Helen Hobbs ◽  
Helen Jessop ◽  
Cristina Bozzolini ◽  
Joachim Burman ◽  
...  

Autologous haematopoietic stem cell transplantation (AHSCT) is increasingly used to treat people with multiple sclerosis (MS). Supported by an evolving evidence base, AHSCT can suppress active inflammation in the central nervous system and induce long-term changes in immune cell populations, thereby stabilizing, and, in some cases, reversing disability in carefully selected MS patients. However, AHSCT is an intensive chemotherapy-based procedure associated with intrinsic risks, including profound cytopenia, infection, and organ toxicity, accompanied by an on-going degree of immuno-compromise and general deconditioning, which can be associated with a transient increase in functional impairment in the early stages after transplantation. Although international guidelines and recommendations have been published for clinical and technical aspects of AHSCT in MS, there has been no detailed appraisal of the rehabilitation needed following treatment nor any specific guidelines as to how this is best delivered by hospital and community-based therapists and wider multidisciplinary teams in order to maximize functional recovery and quality of life. These expert consensus guidelines aim to address this unmet need by summarizing the evidence-base for AHSCT in MS and providing recommendations for current rehabilitation practice along with identifying areas for future research and development.


Sign in / Sign up

Export Citation Format

Share Document